NexgenRx Inc.
NEGXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $615 | -$332 | -$22 | $4,048 |
| Dep. & Amort. | $1,266 | $1,308 | $1,393 | $1,345 |
| Deferred Tax | $365 | $11 | $174 | -$2,038 |
| Stock-Based Comp. | $15 | $36 | $83 | $132 |
| Change in WC | -$1,140 | $229 | $1,736 | -$409 |
| Other Non-Cash | $29 | $26 | $5 | -$62 |
| Operating Cash Flow | $1,150 | $1,277 | $3,369 | $3,016 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$86 | -$77 | -$502 | -$1,380 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$181 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$232 | -$171 | -$117 | -$1,253 |
| Investing Cash Flow | -$498 | -$248 | -$502 | -$1,380 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$102 | -$79 | -$208 | -$809 |
| Stock Issued | $188 | $63 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$908 | -$902 | -$893 | -$131 |
| Other Fin. Act. | $0 | $0 | -$318 | -$35 |
| Financing Cash Flow | -$823 | -$919 | -$1,100 | -$947 |
| Forex Effect | $0 | $0 | -$0 | -$0 |
| Net Chg. in Cash | -$171 | $110 | -$4,293 | $2,493 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,877 | $1,767 | $21,449 | $17,852 |
| End Cash | $1,706 | $1,877 | $17,156 | $20,345 |
| Free Cash Flow | $833 | $1,029 | $2,867 | $1,636 |